- $12.19bn
- $11.80bn
- $2.52bn
- 100
- 44
- 97
- 95
Annual balance sheet for Globus Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 427 | 443 | 446 | 518 | 890 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 148 | 166 | 217 | 505 | 578 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 822 | 865 | 983 | 1,915 | 2,177 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 222 | 226 | 244 | 648 | 612 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,679 | 1,957 | 2,076 | 5,086 | 5,252 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 121 | 140 | 159 | 392 | 856 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 173 | 216 | 230 | 1,088 | 1,074 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,506 | 1,741 | 1,846 | 3,998 | 4,177 |
| Total Liabilities & Shareholders' Equity | 1,679 | 1,957 | 2,076 | 5,086 | 5,252 |
| Total Common Shares Outstanding |